Jennison Associates

Jennison Associates’s UroGen Pharma URGN Stock Holding History

Jennison Associates’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-148,575	Closed	-$4.68M	–	703
2017 Q3	$4.68M	Sell	148,575 -26,835	-15%	-$592K	﹤0.01%	506
2017 Q2	$3.17M	Buy	+175,410	New	+$3.05M	﹤0.01%	523

Other funds holding URGN

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Highline Capital Management New York $51.6M AUM 21.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

DSAM Partners London, United Kingdom $176M AUM 83.78% 1-Year Est. Return